Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 study evaluating the combination of ibrutinib and blinatumomab for relapsed or refractory B-cell acute lymphoblastic leukemia, inclu…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies [Phase 1]
Phase 1 study evaluating CD19/CD22 CAR-T cells in children and young adults with recurrent or refractory B-cell acute lymphoblastic leukemia…